Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent

Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Stanford sues Natera over transplant testing patents

27 March 2019 Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.

Americas

Fed Circ. affirms Stanford genetics patent rejection

26 March 2021 The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.

Americas

Federal Circuit affirms US university’s patent invalidations

19 July 2022 Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.

More on this story

Americas

Stanford sues Natera over transplant testing patents

27 March 2019 Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.

Americas

Fed Circ. affirms Stanford genetics patent rejection

26 March 2021 The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.

Americas

Federal Circuit affirms US university’s patent invalidations

19 July 2022 Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.

More on this story

Americas

Stanford sues Natera over transplant testing patents

27 March 2019 Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.

Americas

Fed Circ. affirms Stanford genetics patent rejection

26 March 2021 The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.

Americas

Federal Circuit affirms US university’s patent invalidations

19 July 2022 Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.